Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
Motley Fool
Thursday, October 17, 2013 - 8:24am
tags:
Parkinson's Disease, pimavanserin, Acadia, Duodopa, AbbVie, LCIG, AFQ056, Novartis
Galapagos sees cystic fibrosis clinical trials in 2014
Yahoo/Reuters
Thursday, October 17, 2013 - 8:22am
tags:
cystic fibrosis, Galapagos
[video]Roche looks to emerging markets for growth
CNBC
Thursday, October 17, 2013 - 8:21am
tags:
Roche, emerging markets, Severin Schwan
4 Ways GlaxoSmithKline plc Will Continue To Lag The Biotechnology Sector
Motley Fool
Thursday, October 17, 2013 - 8:20am
tags:
GSK
FDA panel rejects expanded use of Amarin's Vascepa amid questions for fish oil drug
Yahoo/AP
Wednesday, October 16, 2013 - 3:40pm
tags:
Amarin, FDA, advisory panels, Vascepa
Teva halts Israeli layoff plans amid pressure from labor, government
Fierce Pharma
Wednesday, October 16, 2013 - 11:37am
tags:
Teva, Israel, layoffs
CardioDx IPO may fetch $86.3 million
Mass Device
Wednesday, October 16, 2013 - 11:36am
tags:
devices, CardioDx, IPOs
A Small Cap Pharmaceutical That Is Making Money: Why Tianyin Is Severely Undervalued
Seeking Alpha
Wednesday, October 16, 2013 - 11:34am
tags:
Tianyin Pharmaceutical, China
Former Bayer Employee Can Proceed With Whistleblower Lawsuit
Pharmalot
Wednesday, October 16, 2013 - 11:03am
tags:
Bayer, Baycol, whistleblower lawsuits
Gilead’s Single Tablet HIV Regimen Stribild® Demonstrates Durable Viral Suppression Through Three Years of Therapy
Yahoo
Wednesday, October 16, 2013 - 10:59am
tags:
Giilead, HIV, Stribild
Cancer immunotherapies set to storm onto the market, analysts say
Fierce Biotech
Wednesday, October 16, 2013 - 10:03am
tags:
cancer immunotherapy, Merck, Roche, Bristol-Myers Squibb
Vivus Outlines Key Data Points
Seeking Alpha
Wednesday, October 16, 2013 - 9:31am
tags:
Vivus, obesity, Qsymia
Endocyte's Pipeline Encourages
Yahoo/Zacks
Wednesday, October 16, 2013 - 9:24am
tags:
Endocyte, vintafolide, ovarian cancer, non-small cell lung cancer
Why Is It So Hard To Predict Sales Of New Drugs?
Forbes
Wednesday, October 16, 2013 - 9:08am
tags:
sales forecasts
Can The First Malaria Vaccine Drive GlaxoSmithKline's Growth?
Seeking Alpha
Wednesday, October 16, 2013 - 8:35am
tags:
GSK, vaccines, malaria, Agenus, Daiichi Sankyo, RTS,S, JNJ
Quest Introduces Breast-Cancer Gene Test Rivaling Myriad
Bloomberg
Wednesday, October 16, 2013 - 8:32am
tags:
Quest Diagnostics, Myriad Genetics, breast cancer, BRCA test, BRCA1, BRCA2
Abbott beats forecasts, helped by cost cuts, low taxes
Reuters
Wednesday, October 16, 2013 - 8:19am
tags:
earnings, Abbott Laboratories
Heart device maker St. Jude Medical's profit jumps 49 pct
Reuters
Wednesday, October 16, 2013 - 8:18am
tags:
earnings, St. Jude Medical, devices
Woman Loses Bid To Sue Hospira Over Ongoing Drug Shortage
Pharmalot
Wednesday, October 16, 2013 - 8:18am
tags:
Hospira, drug shortages
FDA approves Novo Nordisk hemophilia A drug
Pharma Times, UK
Wednesday, October 16, 2013 - 8:16am
tags:
FDA, Novo Nordisk, hemophilia A, NovoEight

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.